FTXH

First Trust Nasdaq Pharmaceuticals ETF
NasdaqGMUSDETF / FUND DELAYED
Last price
40.45
▼ 0.31 (0.77%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
40.77
Day high
41.06
Day low
40.08
Volume
108.04K
Market cap
—
P/E (TTM)
25.38
52W range
28.77 – 43.52

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.16% -5.1%
1M
-3.17% -4.3%
3M
+3.92% -0.6%
6M
+19.64% +1.5%
YTD
+22.80% +8.5%
1Y
+36.25% +19.8%
3Y
+58.21% -24.0%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
ABBV AbbVie Inc 7.30%
PFE Pfizer Inc 7.17%
LLY Eli Lilly and Co 7.16%
JNJ Johnson & Johnson 7.13%
MRK Merck & Co Inc 7.04%
VTRS Viatris Inc 3.84%
BIIB Biogen Inc 3.73%
GILD Gilead Sciences Inc 3.64%
AMGN Amgen Inc 3.51%
INCY Incyte Corp 3.48%

Sector exposure

Fund weightings
Healthcare
100.00%

Fund profile

As reported
Fund familyFirst Trust
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.60%
Turnover35.0%
Total net assets$78.64M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on FTXH open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E25.38
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
41.24
-1.91% from price
SMA 20
41.10
-1.59% from price
SMA 50
40.86
-1.00% from price
SMA 100
38.72
+4.47% from price
SMA 200
36.39
+11.14% from price
EMA 12
41.08
-1.54% from price
EMA 26
41.09
-1.55% from price
EMA 50
40.54
-0.22% from price
RSI (14)
42.1
Neutral
MACD (12,26,9)
-0.00
Hist -0.15
ATR (14)
0.73
1.80% of price
Realised vol 30D
14.4%
Annualised
Bollinger upper
42.05
20, 2σ
Bollinger lower
40.15
20, 2σ
50 / 200 cross
Golden
40.86 vs 36.39
Trend bias
Above 200
+11.14%

Options chain

Account required
Expiry
Spot 40.45
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.41
Less volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
14.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-7.5%
Peak to trough
Max drawdown 5Y
-20.5%
Peak to trough
ATR 14
0.73
1.80% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.